abt-199 and Non-alcoholic-Fatty-Liver-Disease

abt-199 has been researched along with Non-alcoholic-Fatty-Liver-Disease* in 1 studies

Other Studies

1 other study(ies) available for abt-199 and Non-alcoholic-Fatty-Liver-Disease

Article	Year
Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18 Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds, Heterocyclic; Cellular Senescence; Dasatinib; Inflammation; Non-alcoholic Fatty Liver Disease; Senotherapeutics; Serine Proteinase Inhibitors; Sulfonamides; Zebrafish	2022

Article

Year

Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation.

International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18

Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds, Heterocyclic; Cellular Senescence; Dasatinib; Inflammation; Non-alcoholic Fatty Liver Disease; Senotherapeutics; Serine Proteinase Inhibitors; Sulfonamides; Zebrafish

2022